The European Society for Medical Oncology’s and the Japanese Society of Medical Oncology’s journal, Annals of Oncology, offers quick and effective peer-reviewed articles on cutting-edge cancer therapies or translational research pertaining to oncology and precision medicine.
Systemic anticancer therapy (with a focus on novel immune therapies and molecularly targeted agents), high-level guidelines, randomised trials (including negative ones), and emerging fields like molecular pathology, bioinformatics, contemporary statistics, and biotechnologies that are becoming important components of personalised medicine are among the main areas of interest. Manuscripts in radiotherapy, surgery, or paediatrics may be taken into consideration if they exhibit a clear relationship to one of the aforementioned fields or if they represent a paradigm change.
The goal of Annals of Oncology, which has a sizable worldwide editorial board made up of professionals in their domains, is to provide the greatest information possible on the rapidly changing and always changing global oncology scene.
Volume 34, 2023
December 2023, Issue 12, pages 1069–1204
November 2023, Issue 11, pages 955–1068
October 2023, Issue 10, pages 829–954.
September 2023, Issue 9, pages 729–828
August 2023, Issue 8, pp. 635–628
July 2023 Issue 7, pages 565–634
June 2023, Issue 6, pp. 503-562
No. 5, May 2023, pages 449–502
No. 4, April 2023, pages 327–448
March 2023 Issue 3, pages 213–326
February 2023, Issue 2, pages 127–212
January 2023 Issue 1 pages 1–124
Reviews
There are no reviews yet.